The Influence of Formulation on the Dissolution Profile of Diclofenac Sodium Tablets

REFERENCES

• Anderson N. H., Bauer M., Boussac N., Khan-Malek R., Munden P., Sardaro M. An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J. Pharm. Biomed. Anal 1998; 17(4–5)811–822
   PubMed Web of Science ®Google Scholar
• Andrade C. M. B., Mylius L. C., Silva N. M., Steppe M., Schuck V. J. A., Shapoval E. S., Dalla Costa T. Evaluation of the dissolution efficiency and similarity factor f2 for the comparison of dissolution profiles in vitro. Rev. Bras. Farm 2002; 83(1–4)19–26
   Google Scholar
• Blanchard J. Formulations factors affecting drug bioavailability. Am. J. Pharm 1978; 150: 132–151
   PubMedGoogle Scholar
• Bolhuis G. K., van Kamp H. V., Lerk C. F., Sessink F. G. M. On the mechanism of action of modern disintegrants. Acta Pharm. Technol 1982; 28: 111–114
   Google Scholar
• Brossard C., Wouessidjewe D. Contrôle de dissolution de formes pharmaceutiques orales solides à libération ralentie. STP Pharma 1990; 6(10)728–741
   Google Scholar
• Chow S. C., Ki F. Y. Statistical comparison between dissolution profiles of drug products. J. Biopharm. Stat 1997; 7(2)241–258
   PubMedGoogle Scholar
• Corrigan O. I., Devlin Y., Butler J. Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro–in vivo correlation. Int. J. Pharm 2003; 254(2)147–154
   PubMedGoogle Scholar
• Farmacopéia Brasileira4th. Informa UK Ltd, Atheneu 2003; 144.1
   Google Scholar
• Ferraz H. G., Pinho J. J. R. G., Ferreira A. M., Ikedo M. T., Pereira R. R. Estudo comparativo do perfil de dissolucao de comprimidos e drágeas contendo diclofenaco potássico disponíveis no mercado brasileiro. Rev. Bras. Farm 1998; 79(1–2)15–16
   Google Scholar
• Flynn G., Yalkowsky S. H., Roseman T. J. Mass transport phenomenon and models: theoretical concepts. J. Pharm. Sci 1974; 63: 479–510
   PubMed Web of Science ®Google Scholar
• Giunchedi P., Conte U., La Manna A. A swellable polymer as carbamazepine dissolution rate enhancer. Boll. Chim. Farm 1990; 9(1)17–20
   Google Scholar
• Gohel C. M., Panchal K. M. Comparison of in vitro dissolution profiles. Pharm. Tech 2000; 24(3)92–103
   Google Scholar
• Gozáles M., Retaco M., Pizzorno M. T., Volonté M. G. Manufacturing technology on the dissolution of ampicillin tablets. Boll.Chim. Farm 1995; 134(8)448–453
   PubMedGoogle Scholar
• Ho H., Liu C., Lin H., Sheu M. The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation. J. Control. Release 1997; 49(2–3)149–156
   Web of Science ®Google Scholar
• Holgado M. A., Carabalo I., Alvarez-Fuentes J., Fernández-Hervás M. J., Fernández-Avérado M., Rabasco A. M. Influence of the diluents and manufacturing methods on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm 1995; 118: 151–160
   Web of Science ®Google Scholar
• Johnson J. R., Wang L., Gordon M. S., Chowhan T. Z. Effect of formulation solubility and hygroscopicity on disintegrating efficiency in tablets prepared by wet granulation, in terms of dissolution. J. Pharm. Sci 1991; 80(5)469–471
   PubMed Web of Science ®Google Scholar
• Khalil E., Sallam A. Interaction of two diclofenac acid salts with copolymers of ammoniomethacrylate: effect of additives and release profiles. Drug Dev. Ind. Pharm 1999; 25(4)419–427
   PubMed Web of Science ®Google Scholar
• Khan K. A. The concept of dissolution efficiency. J. Pharm. Pharmacol 1975; 27: 48–49
   PubMed Web of Science ®Google Scholar
• Ledwidge M. T., Corrigan O. I. Effects of surface active characteristics and solid state forms on the pH solubility profiles of drug–salt systems. Int. J. Pharm 1998; 174(1–2)187–200
   Google Scholar
• Liu C. H., Kao Y. H., Chen S. C., Sokoloski T. D., Sheu M. T. In vitro and in vivo studies of diclofenac sodium controlled-release matrix tablets. J. Pharm. Pharmacol 1995; 47: 360–364
   PubMed Web of Science ®Google Scholar
• Lorenzo-Lamoza M. L., Remuñán-López J. L., Vila-Jato M. J., Alonso M. Design of microencapsulated chitosan micropheres for colonic drug delivery. J. Control. Release 1998; 52: 109–118
   PubMed Web of Science ®Google Scholar
• Moore J. W., Flanner H. H. Mathematical comparison of dissolution profiles. Pharm. Tech 1996; 20(6)64–74
   Google Scholar
• O'Hara T., Dunne A., Butler J., Devane J. A review of methods used to compare dissolution profile data. Pharm. Sci. Tech. Today 1998; 1(5)214–223
   Google Scholar
• Pinho J. J. R. G., Storpitis S. Desenvolvimento e avaliação biofarmacêutica de comprimidos de liberação controlada de cloridrato de metformina empregando meio de dissolução com variação gradual de pH. Braz. J. Pharm. Sci 1999; 35(1)101–109
   Google Scholar
• Polli J. E., Rekhi G. S., Augsburger L. L., Shah V. P. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci 1997; 86: 690–700
   PubMed Web of Science ®Google Scholar
• Prista L. N., Alvez A. C., Morgado R. Tecnologia farmacêutica4th. Informa UK Ltd, Lisboa 1996; 3: 2257
   Google Scholar
• Sallmann A. R. The history of diclofenac. Am. J. Med 1986; 80(Suppl 4B)29–33
   PubMed Web of Science ®Google Scholar
• Shah V. P., Tsong Y., Sathe P., Liu J. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm. Res 1998; 15(6)889–896
   PubMed Web of Science ®Google Scholar
• Sheu M., Chou H., Kao C., Liu C., Sokoloski T. D. Dissolution of diclofenac sodium from matrix tablets. Int. J. Pharm 1992; 85(1–3)57–63
   Google Scholar
• Sielpmann J., Lecomte F., Bodmeier R. Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J. Control. Release 1999; 60: 379–389
   PubMed Web of Science ®Google Scholar
• Silverstein R., Bassler G. C. Spectrometric İdentification of Organic Compounds2nd. Informa UK Ltd, New York 1967; 64–109
   Google Scholar
• Sunada H., Hasegawa M., Makino T., Sakamoto H., Fujita K., Tanino T., Kokubo H., Kawaguchi T. Study of standard tablet formulation based on fluidized-bed granulation. Drug Dev. Ind. Pharm 1998; 24(3)225–233
   PubMed Web of Science ®Google Scholar
• U. S. Department of Health and Human Services. (1997). Guidance for Industry: Modified Release Solid Oral Dosage Forms: Scale-Up and Post Approval Changes (SUPAC-MR): Chemistry, Manufacturing and Controls. In Vivo Dissolution Test and In Vitro Bioequivalence Documentation. Rockville, MD: Center for Drug Evaluation and Research (CDER)http://www.fda.gov/cder/guidance/1214fnl.pdf
   Google Scholar
• Vaughan D. P., Tucker G. T. An analysis of the applications of dissolution effeciency. J. Pharm. Pharmacol 1976; 28: 932–933
   PubMed Web of Science ®Google Scholar
• Villanova J. C. O., Brandão M. A. F., Reis J. E. P., Macedo A. B. J., Pinho J. J. R. G. Estudo comparativo de formas farmacêuticas sólidas contendo dipirona comercializadas no mercado nacional. Braz. J. Pharm. Sci 1999; 35(1)87–93
   Google Scholar
• Zuleger S., Lippold B. C. Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. Int. J. Pharm 2001; 217(1–2)139–152
   PubMed Web of Science ®Google Scholar